Information
-
Trademark
-
87818646
-
International Classifications
-
Filing Date
March 02, 2018
7 years ago
-
Transaction Date
January 17, 2019
6 years ago
-
Status Date
January 17, 2019
6 years ago
-
Location Date
January 17, 2019
6 years ago
-
Status Code
602
-
Current Location
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
Employee Name
SABLE, ERIC MICHAEL
-
Attorney Name
Alex Patel
Law Office Assigned Location Code
M80
-
Owners
Mark Drawing Code
5000
Mark Identification
ATACC
Case File Statements
- CC0000: Color is not claimed as a feature of the mark.
- DM0000: The mark consists of the word ATACC in stylized letters.
- GS0051: Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Biological preparations for the treatment of cancer; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Ferments for pharmaceutical purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Medical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Tumor suppressing agents; Clinical medical reagents; Anti-diabetic pharmaceuticals; Anti-cancer preparations; Cellular function activating agents for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
Case File Event Statements
-
1/17/2019 - 6 years ago
8 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Type: MAB2
-
1/17/2019 - 6 years ago
7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
6/21/2018 - 6 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/21/2018 - 6 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/21/2018 - 6 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/14/2018 - 6 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/9/2018 - 7 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
3/6/2018 - 7 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP